Skip to content

Active Portfolio

Aktis Logo Antiva Biosciences Logo Arialys Logo AshiBio Logo AstronauTx Logo BioIntervene, Inc. Logo Crossbow Therapeutics Logo Cullinan Oncology Logo Deka Biosciences Logo digiTx Partners Logo Dyne Therapeutics Logo elevatebio Logo Entrada Therapeutics, Inc. Logo Firefly Logo Frontier Medicines Logo Harpoon Therapeutics, Inc. (HARP) Logo NextPoint Therapeutics Logo ORNA Logo Photys Therapeutics, Inc. Logo Protego Logo Recode TX Logo Redona Therapeutics Logo ReNAgade Therapeutics Logo Repare Therapeutics, Inc. (RPTX) Logo Reunion Neuroscience Logo TCR2 Therapeutics, Inc. (TCRR) Logo Tetherex Pharmaceuticals Corporation Logo Tizona Therapeutics, Inc. Logo Trishula Therapeutics, Inc. Logo Umoja Biopharma, Inc. Logo Werewolf Therapeutics, Inc. (HOWL) Logo

Includes active MPM and BioImpact Capital portfolio companies, that were private companies at the date of initial investment in funds launched on or after 2010. Excludes passive investments and investments that did not progress scientifically and have been written off. Notwithstanding the foregoing, certain private companies are not illustrated (1) because of confidentiality restrictions or arrangements or (2) because, to the best of MPM’s knowledge, such company does not have a logo or active website. References, either general or specific, to securities and/or issuers are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities. MPM makes no representations, and it should not be assumed, that past investment selection is necessarily indicative of future investment selection or performance. Contact us at to request the most up to date information.